Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Cancer Diagnostics Market is segmented on the basis of technology and application, and geography.
The global cancer diagnostics market, by technology, is categorized into two main segments—platform based and instrument-based. Platform-based segment is further segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), DNA Microarrays, Flow Cytometry and other technologies. Instrument-based segment is further segmented into Imaging (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), mammography, and ultrasound), and Biopsy.
For Sample Report: Global Cancer Diagnostics Market – Trends and Forecast to 2024
On the basis of application the global cancer diagnostics market segmented into lung cancer, breast cancer, colorectal cancer, melanoma and other forms of cancer. Breast cancer diagnosis is expected to hold the largest share of this market in 2015, due to very high prevalence in North America also due to very high cost of mammography instruments. While lung cancer is expected to be the fastest growing application in cancer diagnostics market globally during the forecast period 2017 to 2024.
Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.
To read more about the scope and findings of this report visit: Global Cancer Diagnostics Market is poised to grow at 11.7% till 2024
KEY PLAYERS OPERATING IN GLOBAL CANCER DIAGNOSTICS MARKET:
- Abbott Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Dickinson and Company
- GE Healthcare
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Philips Healthcare
- C.R. Bard, Inc.
- Hologic, Inc.
Table of Content:
1.1. OVERVIEW OF THE GLOBAL CANCER DIAGNOSTICS MARKET
1.2. CURRENCY AND PRICING
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CANCER DIAGNOSTICS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.2.8. EPIDEMIOLOGY FORECASTING MODELS
2.3. GLOBAL CANCER DIAGNOSTICS MARKET: RESEARCH SNAPSHOT
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.2. PLATFORM BASED, BY PRODUCT TYPE
6.2.1. POLYMERASE CHAIN REACTION (PCR)
6.2.2. IN SITU HYBRIDIZATION (ISH)
6.2.3. IMMUNOHISTOCHEMISTRY (IHC)
6.2.4. NEXT GENERATION SEQUENCING (NGS)
6.2.5. DNA MICROARRAYS
6.2.6. FLOW CYTOMETRY
6.3. INSTRUMENT BASED, BY PRODUCT TYPE
7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
9. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE GLOBAL CANCER DIAGNOSTICS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.3. ASIA-PACIFIC (APAC)
9.1.4. LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. GLOBAL CANCER DIAGNOSTICS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.5. MEA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.6. SOUTH AMERICA CANCER DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. GLOBAL CANCER DIAGNOSTICS MARKET, COMPANY PROFILES
11.2. THERMO FISHER SCIENTIFIC
11.3. ILLUMINA, INC.
11.4. GE HEALTHCARE
11.5. SIEMENS HEALTHCARE GMBH
11.7. AGILENT TECHNOLOGIES
11.8. ROCHE DIAGNOSTICS
11.9. KONINKLIJKE PHILIPS N.V.
11.10. BECTON, DICKINSON & COMPANY
11.11. C.R. BARD, INC.
11.12. HOLOGIC, INC.
13. ABOUT DATA BRIDGE MARKET RESEARCH
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
By Product Type, By End User, By Country (Germany, France, United kingdom, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2024
By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024
Company Name: Data Bridge Market Research Private Limited
Contact Person: Varsha Chaudhari
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar